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Changes in the expression of klotho, a b-glucuronidase,
contribute to the development of features that resemble
those of premature aging, as well as chronic renal failure.
Klotho knockout mice have increased expression of the
sodium/phosphate cotransporter (NaPi2a) and
1a-hydroxylase in their kidneys, along with increased serum
levels of phosphate and 1,25-dihydroxyvitamin D. These
changes are associated with widespread soft-tissue
calcifications, generalized tissue atrophy, and a shorter
lifespan in the knockout mice. To determine the role of the
increased vitamin D activities in klotho knockout animals,
we generated klotho and 1a-hydroxylase double-knockout
mice. These double mutants regained body weight and
developed hypophosphatemia with a complete elimination
of the soft-tissue and vascular calcifications that were
routinely found in klotho knockout mice. The markedly
increased serum fibroblast growth factor 23 and the
abnormally low serum parathyroid hormone levels, typical
of klotho knockout mice, were significantly reversed in the
double-knockout animals. These in vivo studies suggest
that vitamin D has a pathologic role in regulating
abnormal mineral ion metabolism and soft-tissue anomalies
of klotho-deficient mice.
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Vitamin D regulates calcium and phosphate homeostasis, and
influences skeletogenesis. 1,25-Dihydroxyvitamin D
(1,25(OH)2D3), the active metabolite of vitamin D, is mostly
formed in the kidney by hydroxylation through the enzyme
1a-hydroxylase (1a(OH)ase).1 Therefore, the effects of
1,25(OH)2D3 can be modified by altering renal 1a(OH)ase
enzyme activity. Genetic inactivation of klotho from mice
resulted in increased serum levels of 1,25(OH)2D3.
2,3
Increased renal expression of the 1a(OH)ase gene in klotho–/–
mice was concomitant with elevated serum levels of
1,25(OH)2D3. Such elevated serum levels of 1,25(OH)2D3
were associated with abnormal soft-tissue and vascular
calcifications in klotho–/– mice.4,5
The klotho protein contains a putative signal sequence at
its N-terminus and a single transmembrane domain near its
C-terminus, which is believed to anchor the protein to the
membrane.6 The klotho gene is predominantly expressed in
the kidneys, parathyroid glands, and brain.7 Such restricted
expression of klotho is thought to confer the tissue specificity
of fibroblast growth factor 23 (FGF23) function. Recently,
klotho has been shown to affect the Naþ -, Kþ -ATPase
activity by increasing the Naþ gradient, and driving the
transepithelial calcium transport in the choroid plexus and
the kidney.6,8 Klotho appears to be actively involved in
mineral ion metabolism; however, the molecular regulation
of klotho is not yet clearly understood, and studies have
shown that vitamin D is a potent inducer of klotho
expression.4
To determine whether increased vitamin D activities in
klotho/ mice are producing abnormal physical, molecular,
and/or biochemical phenotypes of these mice, we generated
and characterized klotho//1a(OH)ase/ double-mutant
mice, and compared their phenotypes with klotho/ single-
mutant mice.
RESULTS AND DISCUSSION
Klotho/ mice developed normally until 2 weeks of age, and
were grossly indistinguishable from their wild-type litter-
mates. However, visible growth retardation was apparent
from 3 weeks onwards in klotho/ mice and was associated
with sluggish movements. Klotho/ mice remained smaller
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during the whole lifespan, developed marked kyphosis, and
usually died by 15 weeks of age. Klotho/ mice also showed
typical features of emphysema in the lungs, with severe
atrophy of the thymus and spleen (Table 1). The serum
calcium and phosphate levels were significantly higher in
klotho/ mice as compared with the wild-type controls.
Furthermore, the renal expression of the 1a(OH)ase gene was
significantly elevated in klotho/ mice, as determined by
quantitative real-time PCR (Figure 1). An increased renal
expression of 1a(OH)ase in klotho/ mice was associated
with increased serum levels of 1,25(OH)2D3 in these mice
(Figure 1). These increased serum 1,25(OH)2D3 levels were
associated with widespread vascular and soft-tissue calcifica-
tions in klotho/ mice. To determine whether increased
levels of 1,25(OH)2D3 in klotho
/ mice mediate abnormal
physical, biochemical, and morphological phenotypes of
klotho/ mice, we generated klotho//1a(OH)ase/ dou-
ble-knockout mice by cross-breeding heterozygous klotho
mutant mice with heterozygous 1a(OH)ase mutant mice.
In contrast to klotho/ mice, klotho//1a(OH)ase/
double-knockout mice were larger in size, and regained
body weight (Figure 2). At 6 weeks of age, the average
body weight of wild-type mice (24.8±1.3 g) was significantly
(Po0.001) higher than klotho/ mice (13.4±0.4 g)
of similar age; compared with the klotho/ mice, the
klotho//1a(OH)ase/ double-knockout mice significantly
(Po0.001) regained body weight (17.7±0.6 g) by 6 weeks of
age (Figure 2). The average body weight of 1a(OH)ase/
knockout mice at 6 weeks of age was 19.8±0.4 g. At 9 weeks
of age, the body weight of wild-type mice had increased to
28±1.3 g, whereas that of the klotho/ mice was 12.6±0.4 g
and that of the klotho//1a(OH)ase/ double-knockout
mice was 20±0.5 g (Figure 2). The body weight patterns of
male and female mice of all four genotypes were very similar
(Figure S1).
Biochemical analysis showed that increased serum calcium
and phosphate levels were reversed, and were relatively low in
klotho//1a(OH)ase/ mice, when compared with
klotho/ mice (Figure 3). Extensive vascular and soft-tissue
calcifications found in the klotho/ mice were completely
eliminated in all the examined tissues, including in the
kidney, of klotho//1a(OH)ase/ mice (Figure 4).
As mentioned above, severe hyperphosphatemia in
klotho/ mice was changed to hypophosphatemia in
klotho//1a(OH)ase/ mice (Figure 3). To determine the
role of sodium/phosphate cotransporter (NaPi2a) in produ-
cing hyperphosphatemia in klotho/ mice, we examined its
expression pattern in kidney sections prepared from various
genotypes using a polyclonal NaPi2a antibody. We found
increased NaPi2a protein expression in the luminal side of
Table 1 | Phenotypes of various mutant mice compared with wild-type mice
Wild type Klotho/ Klotho//1a(OH)ase/ 1a(OH)ase/
Gross appearance
Body weight Normal Reduced (M) Reduced (S) Reduced (S)
Growth Normal Retarded (M) Retarded (S) Retarded (S)
Kyphosis Absent Present Absent Absent
Generalized atrophy
Thymus atrophy Absent Present Absent Absent
Spleen atrophy Absent Present Absent Absent
Muscle atrophy Absent Present Absent Absent
Skin atrophy Absent Present Absent Absent
Intestinal atrophy Absent Present Absent Absent
Morphological changes
Atherosclerosis/arteriosclerosis Absent Present Absent Absent
Ectopic calcifications Absent Present Absent Absent
Emphysema Absent Present Absent Absent
Molecular changes
Renal 1a(OH)ase expression Normal Increased Absent Absent
Renal NaPi2a expression Normal Increased Decreased Decreased
Biochemical changes
Serum 1,25(OH)2D3 Normal High Not done Not done
Serum phosphate Normal High Low Low
Serum calcium Normal High Low Low
Serum PTH Normal Low High High
Serum FGF23 Normal High Low Low
Overall affect
Physical activity Normal Sluggish Normal Normal
Infertility Absent Present Absent Absent
Lifespan Normal Short Normal Normal
FGF23, fibroblast growth factor 23; M, markedly; NaPi2a, sodium/phosphate cotransporter; PTH, parathyroid hormone; S, slightly.
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the proximal tubules of klotho/ mice when compared with
wild-type mice (Figure S2). In contrast, NaPi2a expression
was markedly decreased in klotho//1a(OH)ase/ mice,
and was similar to its expression in 1a(OH)ase–/– mice
(Figure S2), suggesting that increased activity of NaPi2a may
play a role in mediating hyperphosphatemia in klotho/ mice.
Klotho/ mice showed increased vitamin D activities and
abnormal mineral ion homeostasis leading to widespread soft-
tissue calcifications.2,5,9 It has been shown that 1,25(OH)2D3
can induce klotho, as shown by the upregulation of renal
expression of klotho following 1,25(OH)2D3 injection into
wild-type mice.4 The disappearance of soft-tissue calcifications
in klotho//1a(OH)ase/ mice suggested that at least some of
the anomalies found in klotho/ mice were mediated through
increased vitamin D activities. In addition, loss of vitamin D
activities from klotho/ mice resulted in changes from severe
hyperphosphatemia to hypophosphatemia (Figure 3), a pattern
possibly attributable to reduced renal expression of NaPi2a
protein in klotho//1a(OH)ase/ mice. Compared with the
klotho/ mice, our immunostaining data showed a markedly
reduced renal expression of NaPi2a protein in klotho//
1a(OH)ase/ mice (Figure S2).
Earlier studies have shown an inverse correlation between
parathyroid hormone and renal expression of NaPi2a;10,11 we
believe that the decreased activity of NaPi2a in klotho//
1a(OH)ase/ double-knockout mice is partly regulated by
the elevated serum parathyroid hormone levels in these mice
(Figure 5). Such speculation is further substantiated by our
preliminary observations that the serum phosphate levels in
klotho/ mice can be altered in klotho//NaPi2a/ mice,
and that these were similar to the levels found in klotho//
1a(OH)ase/ mice. Taken together, these results suggest that
the hypophosphatemia in klotho//1a(OH)ase/ is mainly
caused by a reduction in renal phosphate reabsorption due to
decreased activity of NaPi2a.
Moreover, the thymuses and spleens in klotho//
1a(OH)ase/ mice were larger than those of the klotho/
mice (Table 1). The pathological changes in the lungs
(Figure 6), intestines (Figure 7), and skin (Figure S3) of
klotho/ mice were dramatically reduced and reversed in
klotho//1a(OH)ase/ mice.
A recent study has found that both Fgf23/ mice and
Fgf23//NaPi2a/ double-knockout mice have high serum
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Figure 1 | Analysis of vitamin D components. Renal expression of 1a-hydroxylase enzyme (1a(OH)ase) and serum levels of
1,25-dihydroxyvitamin D (1,25(OH)2D3) in wild-type (WT) control and klotho
/ mice. Compared with the control mice (n¼ 6), expression of
1a(OH)ase, an enzyme that converts inactive vitamin D components to the active 1,25(OH)2D3, was found to be elevated in kidneys
obtained from klotho/ mice (n¼ 10), as determined by real-time PCR (1±0.27 wild-type vs 20.53±3.9 klotho/). Note that, compared
with control mice (n¼ 8; 38.3±7.5 pmol/l), serum 1,25(OH)2D3 levels were also significantly elevated in klotho/ mice (n¼ 8;
150.25±19.4 pmol/l) (*Po0.001 vs wild-type).
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Figure 2 | Macroscopic phenotype of klotho//1a(OH)ase/
double mutants. Gross phenotype of wild-type, klotho/,
klotho//1a(OH)ase/ (DKO), and 1a(OH)ase/ mice at around
9 weeks of age (upper panel). Body weight curves (lower panel)
for wild-type (WT; n¼ 12), klotho/ (n¼ 19), DKO (n¼ 8), and
1a(OH)ase/ (n¼ 30) mice show that DKO mice are smaller than
wild-type mice but larger than klotho/ mice. This suggests that
inactivation of vitamin D function in klotho/ mice aided in body
weight gains in DKO mice (*Po0.05, klotho/ mice vs DKO mice;
**Po0.001, klotho/ mice vs DKO mice; #Po0.01, wild-type
mice vs klotho/ mice; ##Po0.001, wild-type mice vs klotho/
mice).
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1,25(OH)2D3 levels. This study also showed that they have
discrepant serum phosphate levels (high serum phosphate in
Fgf23/ mice, but low serum phosphate in Fgf23//
NaPi2a/ mice). Despite significantly higher serum
1,25(OH)2D3 levels that were observed in Fgf23
/ mice,
the soft-tissue calcification was reduced or eliminated in
Fgf23//NaPi2a/ mice.12 This result suggests that there
may be a serum 1,25(OH)2D3-independent calcification
process driven by serum phosphate levels.12 In our study,
we have shown that ablation of vitamin D activity from
klotho/ mice can completely eliminate soft-tissue and
vascular calcifications in klotho//1a(OH)ase/ mice. As
klotho//1a(OH)ase/ mice also develop hypophosphate-
mia rather than the severe hyperphosphatemia, it is difficult
to estimate whether the elimination of calcification (Figure
S4) in these mice is due to inactivation of vitamin D activities
or related to reduced serum phosphate levels.
Interestingly, compared with the markedly increased
serum levels of Fgf23 in klotho/ mice, the serum levels of
Fgf23 were significantly reduced in klotho//1a(OH)ase/
mice (Figure 5), suggesting a possible in vivo role of vitamin
D in the induction of Fgf23. It is worth mentioning that
elevated serum levels of 1,25(OH)2D3 can induce an increase
in serum levels of Fgf23.13 Conversely, Fgf23 can reduce
serum levels of 1,25(OH)2D3 by suppressing the expression of
a key converting enzyme, 1a(OH)ase.11 Whether extremely
high serum levels of Fgf23 may exert any toxic effects in
klotho/ mice is an important area of research that would
indicate whether klotho-independent effects of Fgf23 exist.14
It is necessary to mention that the injection of bioactive Fgf23
protein into either wild-type or Fgf23/ mice resulted in
significant reductions in serum levels of phosphate, however,
no such changes were noted in either klotho/ mice or
Fgf23//klotho/ double-knockout mice. This implies that
klotho is essential for the in vivo systemic regulation of
phosphate homeostasis.3
In conclusion, we have shown that vitamin D has a
pathological role in altered phosphate homeostasis, soft-
tissue anomalies, and ectopic calcifications in klotho/ mice.
Despite the crucial biological importance of maintaining
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Figure 3 | Biochemical measurement of serum phosphate and calcium in various genotypes. Note that the serum phosphate (upper
panel) and calcium (lower panel) levels are higher in klotho–/– mice compared with wild-type (WT) mice. Compared with WT mice (n¼ 7;
6.6±0.18), the serum phosphate level was significantly higher in klotho–/– mice (n¼ 5; 11.1±0.39) at 3 weeks of age. Similar
hyperphosphatemia was also observed in klotho–/– mice (n¼ 12; 12.5±0.73) at 6 weeks of age, compared with WT mice (n¼ 11; 7.2±0.35)
of same age. In contrast to klotho–/– mice, the serum phosphate level was significantly reduced in klotho–/–/1a(OH)ase–/– double-knockout
(DKO) mice, both at 3 weeks (n¼ 6; 4.9±0.28) and 6 weeks (n¼ 6; 4.6±0.27) of age. Similar reduction of serum phosphate level was also
observed in 1a(OH)ase–/– mice at 3 weeks (n¼ 5; 5.3±0.67) and 6 weeks (n¼ 8; 5.3±0.26) of age. As for serum calcium (lower panel),
compared with the WT mice (n¼ 7; 7.4±0.1), the serum calcium level was significantly higher in klotho–/– mice (n¼ 6; 9±0.42) at 3 weeks of
age. Similar higher serum level of calcium was also observed in klotho–/– mice (n¼ 6; 10.5±0.36) at 6 weeks of age, compared with the WT
mice (n¼ 9; 8.4±0.42) of same age. In contrast to the klotho–/– mice, the serum calcium level was significantly reduced in DKO mice, both at
3 weeks (n¼ 6; 6.4±0.32) and 6 weeks (n¼ 6; 5.6±0.3) of age. Slightly reduced serum calcium level was also observed in 1a(OH)ase–/– mice
at 3 weeks (n¼ 6; 6.7±0.56) and 6 weeks (n¼ 6; 6.1±0.57) of age (*Po0.001 vs WT; **Po0.001 vs klotho–/–; ***Po0.001 vs klotho–/–;
#Po0.01 vs WT; ##Po0.001 vs klotho–/–; ###Po0.001 vs klotho–/–).
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mineral ion homeostasis, the precise molecular mechanisms
underlying this process are not yet fully understood. Further
studies on in vivo interactions of vitamin D, parathyroid
hormone, FGF23, and klotho will enhance our understanding
of the physiological regulation of mineral ion metabolism.
Such understanding will help us to fine-tune the existing
therapeutic options by manipulating the effects of klotho or
its interacting molecules to treat patients suffering from the
complications of abnormal mineral ion metabolism.15,16
MATERIALS AND METHODS
Generation of double mutant mice
We cross-bred heterozygous klotho and 1a(OH)ase heterozygous
mice to obtain compound heterozygous animals,3,17 which were
WT DKO
WT DKO
Klotho–/–
Klotho–/– 1a(OH)ase–/–
1a(OH)ase–/–
Figure 4 | von Kossa staining of kidney tissues. Renal sections prepared from wild-type (WT), klotho/, klotho//1a(OH)ase/ double-
knockout (DKO), and 1a(OH)ase/ mice showing extensive calcifications in the kidneys of klotho/ mice. Inactivation of vitamin D from
klotho/ mice completely eliminated calcification from DKO mice (magnification  20). The macroscopic features of corresponding
kidneys are shown in the upper panel.
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Figure 5 | Biochemical measurements of serum PTH and Fgf23
in various genotypes. Note that compared with wild-type mice
(n¼ 4; 102.5±69), serum parathyroid hormone (PTH) levels are
markedly reduced in klotho–/– mice (n¼ 8; 46.8±16) but are
significantly higher in both klotho–/–/1a(OH)ase–/– double-knockout
(DKO) mice (n¼ 4; 2945±560) and 1a(OH)ase–/– mice (n¼ 4;
2443±610). The average serum levels of fibroblast growth factor
23 (FGF23) are higher in klotho–/– mice (n¼ 5; 6857 pg/ml), as
compared with the wild-type mice (n¼ 5; 134 pg/ml). In contrast
to the klotho–/– mice, serum FGF23 levels are significantly reduced
in DKO mice, (n¼ 5; 6.7 pg/ml). The average serum levels of FGF23
in 1a(OH)ase–/– mice (n¼ 5; 120 pg/ml) are also lower than in the
klotho–/– mice (#Po0.01 vs wild-type; ##Po0.001 vs wild-type;
**Po0.001 vs klotho–/–).
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Figure 6 | Histological analysis of lung tissues. Hematoxylin and
eosin-stained sections of the lung tissues of 6-week-old wild-type
(WT), klotho/, klotho//1a(OH)ase/ double-knockout (DKO),
and 1a(OH)ase/ mice. Note that, compared with wild-type mice,
there is marked expansion of alveolar spaces (emphysema) in
klotho/ mice. Such pulmonary emphysematous changes are
seen neither in the DKO mice nor in the 1a(OH)ase/ mice (lung,
magnification  10).
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then interbred to generate the desired double homozygous mutants
(klotho//1a(OH)ase/). Routine PCR using genomic DNA
extracted from tail clips, was performed for genotyping of the
various groups of mice.18,19 Mice were maintained in accordance
with the NIH Guide for the Care and Use of Laboratory Animals,
and were employed using protocols approved by the institution’s
subcommittee on animal care.
Gross phenotype
The total body weight of all mice was taken every 3–5 days starting at
3 weeks of age until death. The survival rates of control, klotho/,
and double-mutant klotho//1a(OH)ase/ mice were recorded
until death.
Biochemical measurements
Blood was obtained by cheek pouch bleeding at different time points
from wild-type, klotho/, klotho//1a(OH)ase/, and
1a(OH)ase/ mice. Serum was isolated by centrifugation at
3000 g for 10 min and was stored at 80 1C. Serum phosphorus
and calcium were determined by colorimetric measurements using
the Stanbio Phosphorus Liqui-UV Test and Calcium (Arsenazo)
LiquiColor Test, respectively. Serum levels of parathyroid hormone
were measured in serum obtained from wild-type, klotho/,
klotho//1a(OH)ase/, and 1a(OH)ase/ mice using a commer-
cial kit (Immutopics Inc., San Clemente, CA, USA). The level of
1,25(OH)2D3 was measured in serum obtained from different
genotypes using a kit purchased from Immunodiagnostic Systems
Ltd, Fountain Hills, AZ, USA. The serum level of Fgf23 was
measured by ELISA (Kinos Inc., Tokyo, Japan), as described
earlier.20
Histological analyses
Histological sections were prepared from various soft tissues that
were routinely fixed in either 10% buffered formalin or Carnoy’s
solution. The sections were stained with hematoxylin and eosin,
periodic acid-Schiff, periodic acid-Schiff methenamine silver,
Masson’s trichome, and von Kossa.21,22 Histological changes in
various groups were documented under light microscopy.
Calcification analyses
To determine the effects of vitamin D inactivation on soft-tissue and
vascular calcification in klotho//1a(OH)ase/ mice, sections were
prepared from lung, kidney, and gastrointestinal tract, and were
stained with von Kossa to visualize the mineralized tissue by light
microscopy. The von-Kossa-stained sections of klotho//
1a(OH)ase/ mice were compared with similarly stained sections
from wild-type, klotho/, and 1a(OH)ase/ mice. For quantifica-
tion of calcification, the relative area of von Kossa staining was
determined by calculating the ratio of positively stained pixels and
unstained area per high-power microscopic field ( 20) on
histological images taken from von-Kossa-stained kidney slides.
The von Kossa staining was quantified using an image analyzer
(Photoshop software; Adobe Systems, San Jose, CA, USA).
Expression of 1a(OH)ase
Total RNA isolated from the kidneys of each group of mice was used
to detect relative expression of 1a(OH)ase mRNA by real-time PCR,
as described earlier.23,24 Real-time PCR was performed in duplicate,
and all reactions were controlled by standards. The sequences of the
primers used to detect 1a(OH)ase were forward 50-TCA GAT GTT
TGC CTT TGC CC-30 and reverse 50-TGG TTC CTC ATC GCA
GCT TC-30.
Expression of NaPi2a
Immunostaining was performed as described earlier.20,25 In brief,
OCT-embedded frozen sections were incubated with blocking
solution for 30 min and then overnight with polyclonal anti-NaPi2a
antibody (dilution, 1:100; Alpha Diagnostic, San Antonio, TX, USA)
at 4 1C. The slides were washed with phosphate buffered saline and
incubated with fluorescein isothiocyanate-leveled anti-rabbit sec-
ondary antibody (dilution, 1:100) for 30 min. After phosphate
buffered saline wash, coverslips were placed on slides using 4,6-
diamidino-2-phenylindole-containing mounting media. The expres-
sion of NaPi2a was visualized under UV light, using immuno-
fluorescence microscopy. Rabbit serum and phosphate buffered
saline, instead of primary antibody, were used as negative controls.
Statistics
Statistically significant differences between groups were evaluated by
the Student’s t-test for a comparison between two groups or by one-
way analysis of variance followed by Tukey’s test for multiple
comparisons. All values were expressed as mean±s.e. A P-value of
less than 0.05 was considered to be statistically significant. All
analyses were performed using Microsoft Excel.
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SUPPLEMENTARY MATERIAL
Figure S1. Body weight patterns of male and female mice.
Figure S2. Expression of NaPi2a.
Figure S3. Histological analysis of skin tissues.
WT Klotho–/–
DKO 1(OH)ase–/–
Figure 7 | Histological analysis of intestine. Compared with
wild-type (WT) mice, there is marked atrophy of the intestinal wall
(arrows) in klotho/ mice. Such atrophic changes of the intestine
are seen neither in the klotho//1a(OH)ase/ double-knockout
(DKO) mice nor in the 1a(OH)ase/ single-knockout mice
(intestine, magnification  10).
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Figure S4. Quantification of calcification.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
REFERENCES
1. Lanske B, Razzaque MS. Vitamin D and aging: old concepts and new
insights. J Nutr Biochem 2007; 18: 771–777.
2. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho
gene leads to a syndrome resembling ageing. Nature 1997; 390: 45–51.
3. Nakatani T, Bara S, Ohnishi M et al. In vivo genetic evidence for klotho-
dependent, fibroblast growth factor (FGF23)-mediated regulation of
systemic phosphate homeostasis. FASEB J 2009; 23: 433–441.
4. Tsujikawa H, Kurotaki Y, Fujimori T et al. Klotho, a gene related to a
syndrome resembling human premature aging, functions in a negative
regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17:
2393–2403.
5. Memon F, El-Abbadi M, Nakatani T et al. Does Fgf23-klotho activity
influence vascular and soft tissue calcification through regulating mineral
ion metabolism? Kidney Int 2008; 74: 566–570.
6. Nabeshima Y, Imura H. alpha-Klotho: a regulator that integrates calcium
homeostasis. Am J Nephrol 2008; 28: 455–464.
7. Li SA, Watanabe M, Yamada H et al. Immunohistochemical localization of
Klotho protein in brain, kidney, and reproductive organs of mice. Cell
Struct Funct 2004; 29: 91–99.
8. Razzaque MS. Klotho and Na+,K+-ATPase activity: solving the calcium
metabolism dilemma? Nephrol Dial Transplant 2008; 23: 459–461.
9. Lanske B, Razzaque MS. Premature aging in klotho mutant mice: cause or
consequence? Ageing Res Rev 2007; 6: 73–79.
10. Segawa H, Yamanaka S, Ohno Y et al. Correlation between
hyperphosphatemia and type II Na-Pi cotransporter activity in klotho
mice. Am J Physiol Renal Physiol 2007; 292: F769–F779.
11. Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23
demonstrates an essential physiological role of FGF23 in phosphate and
vitamin D metabolism. J Clin Invest 2004; 113: 561–568.
12. Sitara D, Kim S, Razzaque MS et al. Genetic evidence of serum phosphate-
independent functions of FGF-23 on bone. PLoS Genet 2008; 4: e1000154.
13. Saito H, Maeda A, Ohtomo S et al. Circulating FGF-23 is regulated by
1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 2005;
280: 2543–2549.
14. Razzaque MS. Does FGF23 toxicity influence the outcome of chronic
kidney disease? Nephrol Dial Transplant 2009; 24: 4–7.
15. Razzaque MS. Can fibroblast growth factor 23 fine-tune therapies for
diseases of abnormal mineral ion metabolism? Nat Clin Pract Endocrinol
Metab 2007; 3: 788–789.
16. Razzaque MS. FGF23-mediated regulation of systemic phosphate
homeostasis: is klotho an essential player? Am J Physiol Renal Physiol.
doi:10.1152/ajprenal.90538.2008.
17. Razzaque MS, Sitara D, Taguchi T et al. Premature ageing-like phenotype
in fibroblast growth factor 23 null mice is a vitamin-D mediated process.
FASEB J 2006; 20: 720–722.
18. Sitara D, Razzaque MS, St-Arnaud R et al. Genetic ablation of
vitamin D activation pathway reverses biochemical and skeletal
anomalies in Fgf-23-null animals. Am J Pathol 2006; 169:
2161–2170.
19. Dardenne O, Prud’homme J, Arabian A et al. Targeted inactivation of the
25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an
animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001;
142: 3135–3141.
20. DeLuca S, Sitara D, Kang K et al. Amelioration of the premature
ageing-like features of Fgf-23 knockout mice by genetically
restoring the systemic actions of FGF-23. J Pathol 2008; 216:
345–355.
21. Zha Y, Taguchi T, Nazneen A et al. Genetic suppression of GH-IGF-1
activity, combined with lifelong caloric restriction, prevents age-related
renal damage and prolongs the life span in rats. Am J Nephrol 2008; 28:
755–764.
22. Liu D, Nazneen A, Taguchi T et al. Low-dose local kidney irradiation
inhibits progression of experimental crescentic nephritis by promoting
apoptosis. Am J Nephrol 2008; 28: 555–568.
23. Razzaque MS, Foster CS, Ahmed AR. Role of collagen-binding heat shock
protein 47 and transforming growth factor-beta1 in conjunctival scarring
in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003; 44:
1616–1621.
24. Medici D, Razzaque MS, Deluca S et al. FGF-23-Klotho signaling stimulates
proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 2008;
182: 459–465.
25. Razzaque MS, Taguchi T. Collagen-binding heat shock protein (HSP) 47
expression in anti-thymocyte serum (ATS)-induced glomerulonephritis.
J Pathol 1997; 183: 24–29.
1172 Kidney International (2009) 75, 1166–1172
o r i g i n a l a r t i c l e M Ohnishi et al.: Vitamin-D and klotho
